← SynDRA
DORZAGLIATIN
SynDRA canonical compound SYN0039654 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GCK |
| Mechanism of action | glucokinase activator |
| Indication | diabetes mellitus |
| Disease area | endocrinology |
All known targets
Mechanisms of action (all sources)
- GCK ACTIVATOR
- Hexokinase type IV activator
- glucokinase activator
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- Dorzagliatine
- Dorzagliatina
- HMS5552
- Sinogliatin
- HMS-5552
- RO-5305552
- RO5305552
- UNII-X59W6980E8
- X59W6980E8
- Dorzagliatin [INN]
- Dorzagliatin [USAN:INN]
- SCHEMBL1079619
- HMUMWSORCUWQJO-QAPCUYQASA-N
- AKOS030527745
- (S)-2-(4-(2-chlorophenoxy)-2-oxo-2,5
- (S)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(1-((R
- (S)-2-[4-(2-chloro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-((R)-2,3-dihydroxy-propyl)-1H-pyrazol-3-yl]-amide
- (2S)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(1
- HMS 5552
- dorzagliatina
- dorzagliatine
- dorzagliatinum
- RefChem:135682
- Dorzagliatin (USAN)
- DORZAGLIATIN [USAN]
- Dorzagliatin?
- HuaTangNing
- Dorzagliatin (Standard)
- C22H27ClN4O5
- DORZAGLIATIN [WHO-DD]
- orb1308371
- SCHEMBL29386763
- GTPL12124
- CHEBI:234514
- GLXC-25388
- EX-A4478
- MFCD22376579
- s6921
- HMS5552;RO5305552;Sinogliatin
Look up DORZAGLIATIN in the interactive SynDRA portal →